FDA approves Alzheimer’s drug lecanemab amid safety concerns
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
176
total citations
- FWCI
- 98.24
- Percentile
- 100%
- References
- 2
Citations per year
Authors
1Topics & keywords
Topics
Keywords
- Landmark
- Shadow (psychology)
- Medicine
- Drug approval
- Drug
- Pharmacology
- Psychology
- Geography
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.